Recently, the expression of PDPN in cancer cells was demonstrated to promote tumor cell motility and tumor lymphangiogenesis in vitro, and one supplementary clinical trial showed that PDPN expression correlated with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx. Here, PDPN is linked to squamous cell carcinoma.